Providers & Plans

What if the standard approach to heart disease was proactive, not reactive?

Nearly 40% of new heart failure patients are diagnosed in acute care settings, when almost half of these patients had potential symptoms in the prior six months1.

Caption Care enables you to find and address heart failure earlier across your member population — before undiagnosed issues become serious.

Transforming the heart disease patient journey

Current approach

Patient experiences acute event

Expensive ambulance ride

Patient admitted to ED and waits for an echo

Expensive inpatient stay

Reactive cycle repeats

New approach

Echo scheduled for at-risk patient

Echo performed in convenient location

Cardiologist generates actionable clinical report

Patient receives the right care prior to an acute event

Money, time, and lives saved

Turnkey, end-to-end echo programs include:

  • Target Population Identification
  • Patient Engagement
  • Appointment Scheduling
  • In-Clinic & In-Home Scanning
  • Clinical Read & Report Delivery
  • Add-on Care Management Available

Right-sizing cardiac care

Early heart disease detection helps drive:
  • Better Outcomes
  • Lower Costs
  • More Accurate Risk Scoring
  • Right Care, Right Time, Right Provider, Right Setting
Unlocking value for:
  • ACOs & Value-Based Care Providers
  • Health Plans
  • Employer Benefit Groups
  • Concierge Medicine Providers
  • Gaps Closure, Home Health, & Chronic Care Solutions

Advancing the standard of care to meet cardiac screening guidelines

Echocardiography recommendations across disease states:
  • Proactive evaluation of patients with risk factors2
  • Asymptomatic patients with hypertension3
  • Screening for Stage B & C heart failure through echo and/or BNP test4
  • Baseline evaluation for new cancer diagnoses and long-term follow-up based on risk of cardiotoxicity5
  • Before the start of dialysis, regardless of symptoms
  • 1-3 months into dialysis
  • 3-yearly intervals thereafter6
Risk factors for development of heart failure2:
  • Hypertension
  • Coronary artery disease
  • Diabetes mellitus or metabolic syndrome
  • Morbid obesity 
  • Current or former smoker
  • Chronic kidney disease stage III or greater 
  • Peripheral arterial disease
  • Prior stroke or transient ischemic attack
  • Exposure to cardiotoxic agents 
  • Positive family history of a cardiomyopathy
  • Obstructive sleep apnea (for right ventricular failure)
  • History of long COVID
  1. Sandhu AT, Tisdale RL, Rodriguez F, et al. Disparity in the Setting of Incident Heart Failure Diagnosis. Circ Heart Fail. 2021;14(8):e008538. doi:10.1161/CIRCHEARTFAILURE.121.008538
  2. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263-e421. doi:10.1016/j.jacc.2021.12.012
  3. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):e50-e103. doi:10.1016/j.jacc.2010.09.001
  4. Pop-Busui R, Januzzi JL, Bruemmer D, et al. Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association. Diabetes Care. 2022;45(7):1670-1690. doi:10.2337/dci22-0014
  5. Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229-4361. doi:10.1093/eurheartj/ehac244
  6. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1-S153.